BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33445991)

  • 1. Physiologic and hemodynamic changes in patients undergoing open abdominal cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Kim MH; Yoo YC; Bai SJ; Lee KY; Kim N; Lee KY
    J Int Med Res; 2021 Jan; 49(1):300060520983263. PubMed ID: 33445991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Global End-Diastolic Volume (GEDV) Could Be More Appropiate to Fluid Management Than Central Venous Pressure (CVP) During Closed Hyperthermic Intrabdominal Chemotherapy with CO
    Redondo FJ; Padilla D; Villarejo P; Baladron V; Faba P; Sánchez S; Muñoz-Rodríguez JR; Bejarano N
    J Invest Surg; 2018 Aug; 31(4):321-327. PubMed ID: 28557569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of bioreactance and pulse power analysis in measuring cardiac index during cytoreductive abdominal surgery with hyperthermic intraperitoneal chemotherapy (HIPEC).
    Ylikauma LA; Tuovila MJ; Ohtonen PP; Erkinaro TM; Vakkala MA; Takala HT; Liisanantti JH; Kaakinen TI
    BMC Anesthesiol; 2023 Jan; 23(1):38. PubMed ID: 36721097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and respiratory implications of high intra-abdominal pressure during HIPEC.
    Reis ACV; Kusamura S; Azmi N; Fumagalli L; Piccioni F; Valenza F; Baratti D; Guaglio M; Cavalleri A; Garrone G; Barretta F; Deraco M
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1896-1901. PubMed ID: 32147425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perianesthesia Measurement During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Procedure: A Case Report and Review of the Literature.
    Li D; Henker R; Zhang F
    J Perianesth Nurs; 2019 Feb; 34(1):198-205. PubMed ID: 29685726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic Monitoring During Heated Intraoperative Intraperitoneal Chemotherapy Using the FloTrac/Vigileo System.
    Mavroudis C; Alevizos L; Stamou KM; Vogiatzaki T; Eleftheriadis S; Korakianitis O; Tentes AA; Iatrou C
    Int Surg; 2015 Jun; 100(6):1033-9. PubMed ID: 25590363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four different methods of measuring cardiac index during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Heijne A; Krijtenburg P; Bremers A; Scheffer GJ; Malagon I; Slagt C
    Korean J Anesthesiol; 2021 Apr; 74(2):120-133. PubMed ID: 32819047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
    Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y
    World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-abdominal pressure, Cardiac Index and vascular resistance during hyperthermic intraperitoneal chemotherapy: a prospective observational study.
    Schluermann CN; Hoeppner J; Benk C; Schmidt R; Loop T; Kalbhenn J
    Minerva Anestesiol; 2016 Feb; 82(2):160-9. PubMed ID: 25971283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Goal-directed therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a prospective observational study.
    Esteve-Pérez N; Ferrer-Robles A; Gómez-Romero G; Fabián-Gonzalez D; Verd-Rodriguez M; Mora-Fernandez LC; Segura-Sampedro JJ; Tejada-Gavela S; Morales-Soriano R
    Clin Transl Oncol; 2019 Apr; 21(4):451-458. PubMed ID: 30218305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study.
    Yu P; Ye Z; Dai G; Zhang Y; Huang L; Du Y; Cheng X
    BMC Cancer; 2020 Nov; 20(1):1108. PubMed ID: 33198674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
    Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
    Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Coagulation in Cancer Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Treatment (HIPEC)-A Systematic Review.
    Lundbech M; Damsbo M; Krag AE; Hvas AM
    Semin Thromb Hemost; 2024 Apr; 50(3):474-488. PubMed ID: 36828005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.
    Cravioto-Villanueva A; Cavazos M; Luna-Perez P; Martinez-Gomez H; Ramirez ML; Solorzano J; Montiel H; Esquivel J
    Surg Today; 2016 Aug; 46(8):979-84. PubMed ID: 27138212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel prognostic score for outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with metachronous peritoneal carcinomatosis.
    Chin KM; Tan GHC; Chia CS; Ong JCA; Teo MCC
    ANZ J Surg; 2020 Oct; 90(10):1958-1964. PubMed ID: 32159299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Incidence, management and outcomes.
    Valle SJ; Alzahrani N; Alzahrani S; Traiki TB; Liauw W; Morris DL
    Surg Oncol; 2016 Sep; 25(3):315-20. PubMed ID: 27566038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25-year experience.
    Nikiforchin A; Gushchin V; King MC; Baron E; Nieroda C; Sittig M; Sardi A
    J Surg Oncol; 2021 Mar; 123(4):1030-1044. PubMed ID: 33524164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).
    Koemans WJ; van der Kaaij RT; Boot H; Buffart T; Veenhof AAFA; Hartemink KJ; Grootscholten C; Snaebjornsson P; Retel VP; van Tinteren H; Vanhoutvin S; van der Noort V; Houwink A; Hahn C; Huitema ADR; Lahaye M; Los M; van den Barselaar P; Imhof O; Aalbers A; van Dam GM; van Etten B; Wijnhoven BPL; Luyer MDP; Boerma D; van Sandick JW
    BMC Cancer; 2019 May; 19(1):420. PubMed ID: 31060544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Best practice for perioperative management of patients with cytoreductive surgery and HIPEC.
    Raspé C; Flöther L; Schneider R; Bucher M; Piso P
    Eur J Surg Oncol; 2017 Jun; 43(6):1013-1027. PubMed ID: 27727026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy, Part I: Introduction and Indications.
    Dunn D
    AORN J; 2019 Nov; 110(5):479-499. PubMed ID: 31660604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.